Regulation of oxidative stress and cardioprotection in diabetes mellitus
- PMID: 20066132
- PMCID: PMC2801856
- DOI: 10.2174/157340308786349426
Regulation of oxidative stress and cardioprotection in diabetes mellitus
Abstract
Analysis of the Framingham data has shown that the risk of heart failure is increased substantially among diabetic patients, while persons with the metabolic syndrome have an increased risk of both atherosclerosis and diabetes mellitus. Sleep apnea may be related to the metabolic syndrome and systemic inflammation through hypoxia, which might also cause the cardiac remodeling by increased oxidative stress. On the other hand, the renin-angiotensin system is activated in diabetes, and local angiotensin II production may lead to oxidative damage via the angiotensin II type 1 receptor. Basic and clinical data indicate that angiotensin II receptor blockers have the potential to preserve left ventricular function and prevent cardiac remodeling that is exaggerated by oxidative stress in patients with diabetes. Thus, alleviation of oxidative stress might be one possible strategy in the treatment of diabetic patients associated with sleep apnea.
Keywords: Oxidative stress; diabetes mellitus; hypoxia; remodeling.; sleep apnea.
Figures




Similar articles
-
Efficacy of olmesartan and nifedipine on recurrent hypoxia-induced left ventricular remodeling in diabetic mice.Life Sci. 2010 Feb 27;86(9-10):322-30. doi: 10.1016/j.lfs.2009.12.013. Epub 2010 Jan 7. Life Sci. 2010. PMID: 20060397
-
Angiotensin-II receptor blocker exerts cardioprotection in diabetic rats exposed to hypoxia.Circ J. 2006 Jun;70(6):787-92. doi: 10.1253/circj.70.787. Circ J. 2006. PMID: 16723804
-
Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.Am J Hypertens. 2005 Jan;18(1):121-8. doi: 10.1016/j.amjhyper.2004.07.001. Am J Hypertens. 2005. PMID: 15691626 Review.
-
Cardiovascular and renal protection in type 2 diabetes mellitus: the role of calcium channel blockers.J Am Soc Nephrol. 2002 Nov;13 Suppl 3:S216-23. doi: 10.1097/01.asn.0000034687.62568.9b. J Am Soc Nephrol. 2002. PMID: 12466317 Review.
-
Impact of the renin-angiotensin-aldosterone-system on cardiovascular and renal complications in diabetes mellitus.Curr Vasc Pharmacol. 2010 Mar;8(2):189-97. doi: 10.2174/157016110790886947. Curr Vasc Pharmacol. 2010. PMID: 19485896 Review.
Cited by
-
(-)-Epicatechin rich cocoa mediated modulation of oxidative stress regulators in skeletal muscle of heart failure and type 2 diabetes patients.Int J Cardiol. 2013 Oct 9;168(4):3982-3990. doi: 10.1016/j.ijcard.2013.06.089. Epub 2013 Jul 17. Int J Cardiol. 2013. PMID: 23870648 Free PMC article. Clinical Trial.
-
A Novel ALDH2 Activator AD-9308 Improves Diastolic and Systolic Myocardial Functions in Streptozotocin-Induced Diabetic Mice.Antioxidants (Basel). 2021 Mar 13;10(3):450. doi: 10.3390/antiox10030450. Antioxidants (Basel). 2021. PMID: 33805825 Free PMC article.
References
-
- Everhart JE, Pettitt DJ, Knowler WC, et al. Medial arterial calcification and its association with mortality and complications of diabetes. Diabetologia. 1988;31:16–23. - PubMed
-
- Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570–81. - PubMed
-
- Klein R, Klein BE, Moss SE, Cruickshanks KJ, Brazy PC. The 10-year incidence of renal insufficiency in people with type 1 diabetes. Diabetes Care. 1999;22:743–51. - PubMed
-
- Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1996;27:567–74. - PubMed
-
- Tooke JE. Microvascular function in human diabetes. A physiological perspective. Diabetes. 1995;44:721–6. - PubMed
LinkOut - more resources
Full Text Sources